Concise and clinically focused, Gout, by Drs. Naomi Schlesinger and Peter E. Lipsky, provides a one-stop overview of recent developments regarding this common form of inflammatory arthritis. Impacting an estimated 8.3 million people in the U.S. alone, gout is seen frequently by both primary care physicians as well as rheumatologists. This resource provides detailed coverage of the epidemiology, causes, diagnosis, management, and treatment of patients with both acute and chronic gout.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. List of Contributors - p. v 6. Preface - p. ix 7. Dedication - p. xi 8. Chapter 1. Hyperuricemia and the Silent Deposition of Monosodium Urate Crystals - p. 1 9. Chapter 2. Genetics of Hyperuricemia and Gout - p. 9 10. Chapter 3. Immunoinflammatory Nature of Gout - p. 29 11. Chapter 4. Tophi: Clinical and Biological Features - p. 37 12. Chapter 5. Crystal Analysis in Synovial Fluid - p. 47 13. Chapter 6. Epidemiology of Gout and Hyperuricemia - p. 59 14. Chapter 7. Comorbidities in Gout - p. 73 15. Chapter 8. Imaging of Gout - p. 89 16. Chapter 9. Gout Classification and Diagnosis - p. 101 17. Chapter 10. Clinical Features of Gout and Its Impact on Quality of Life - p. 113 18. Chapter 11. Quality of Life - p. 119 19. Chapter 12. Treatment Guidelines: The Good, the Bad, the Ugly - p. 141 20. Chapter 13. Nonpharmacologic Treatment of Gout - p. 155 21. Chapter 14. Pharmacologic Treatments: Acute Gout - p. 163 22. Chapter 15. Current Pharmacological Treatments of Chronic Gout - p. 169 23. Chapter 16. Treat to Target - p. 179 24. Chapter 17. Drugs in the Pipeline - p. 185 25. Epilogue - p. 197 26. Index - p. 199
Concise and clinically focused, Gout, by Drs. Naomi Schlesinger and Peter E. Lipsky, provides a one-stop overview of recent developments regarding this common form of inflammatory arthritis. Impacting an estimated 8.3 million people in the U.S. alone, gout is seen frequently by both primary care physicians as well as rheumatologists. This resource provides detailed coverage of the epidemiology, causes, diagnosis, management, and treatment of patients with both acute and chronic gout.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. List of Contributors - p. v 6. Preface - p. ix 7. Dedication - p. xi 8. Chapter 1. Hyperuricemia and the Silent Deposition of Monosodium Urate Crystals - p. 1 9. Chapter 2. Genetics of Hyperuricemia and Gout - p. 9 10. Chapter 3. Immunoinflammatory Nature of Gout - p. 29 11. Chapter 4. Tophi: Clinical and Biological Features - p. 37 12. Chapter 5. Crystal Analysis in Synovial Fluid - p. 47 13. Chapter 6. Epidemiology of Gout and Hyperuricemia - p. 59 14. Chapter 7. Comorbidities in Gout - p. 73 15. Chapter 8. Imaging of Gout - p. 89 16. Chapter 9. Gout Classification and Diagnosis - p. 101 17. Chapter 10. Clinical Features of Gout and Its Impact on Quality of Life - p. 113 18. Chapter 11. Quality of Life - p. 119 19. Chapter 12. Treatment Guidelines: The Good, the Bad, the Ugly - p. 141 20. Chapter 13. Nonpharmacologic Treatment of Gout - p. 155 21. Chapter 14. Pharmacologic Treatments: Acute Gout - p. 163 22. Chapter 15. Current Pharmacological Treatments of Chronic Gout - p. 169 23. Chapter 16. Treat to Target - p. 179 24. Chapter 17. Drugs in the Pipeline - p. 185 25. Epilogue - p. 197 26. Index - p. 199
